Wednesday, February 21, 2018 10:15 PM ET
Abbott Laboratories (ABT) sees Significant Insider Selling Continuing
One Abbott Laboratories insider Stephen R Fussell, Officer, today, disposed of 42,709 shares having a market value of approximately $2,550,813, as disclosed in a form 4 document filed with the SEC. There have been 4 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 193,777 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 236,486 shares and have averaged 47,297 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Abbott Laboratories is above its 119-company peer group average. The Pharmaceuticals peer group saw 65 buy/sell trades during this period for an average of 0.5 transactions per company. However, the number of shares traded per transaction by Abbott Laboratories insiders is lower than its peers. Within the peer group there were 1,828,831 shares purchased and 4,257,267 shares sold with company insiders disposing of 37,361 shares on average over this time period.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data sourced in evaluating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.